papaverine has been researched along with cardiovascular agents in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (84.62) | 18.7374 |
| 1990's | 1 (3.85) | 18.2507 |
| 2000's | 2 (7.69) | 29.6817 |
| 2010's | 1 (3.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amvros'eva, TV; Andreeva, OT; Goretskaia, IS; Klimashevskaia, LM; Vervetchenko, SG; Vladyko, GV; Votiakov, VI | 1 |
| Björnsson, OG; Kobayashi, K; Williamson, JR | 1 |
| VILLINGER-KWERCH, H | 1 |
| HOPPER, GR; MINEUR, HJ; MOON, D; SCHWARTZ, SH | 1 |
| GOLDBERG, AA; SHAPERO, M | 2 |
| BINIECKI, S; RYLSKI, L | 1 |
| IGLAUER, A; SCOTT, RC; SIMON, DL | 1 |
| PYKHTINA, AA | 1 |
| TEN BERGE, B; VAN ASSEN, FJ | 1 |
| COBBIN, LB; THORP, RH | 1 |
| KISIN, Ie | 2 |
| KESSLER, R; WAGNER, H | 1 |
| SZEBENI, A | 1 |
| FLEURY, C; FROMMEL, E; GOLD-AUBERT, P; VINCENT, D | 1 |
| FRONEK, A; GANZ, V; HAMMER, J | 1 |
| SETNIKAR, I | 1 |
| NIKOLOVA, M; SHEIKOVA, Zh | 2 |
| PETRANYI, G; SZEGEDI, G | 1 |
| INOUE, S; TOKUDA, G | 1 |
| DUCHENE-MARULLAZ, P; VACHER, J | 1 |
| Arapi, SM; Karavidas, AI; Lazaros, GA; Zacharoulis, AA | 1 |
| Imaizumi, M; Iwata, H; Murakami, E; Takemura, H | 1 |
| Cao, F; Chen, X; Kim, TH; Ma, N; Niu, G; Sun, Z; Tong, G | 1 |
26 other study(ies) available for papaverine and cardiovascular agents
| Article | Year |
|---|---|
[Antiviral properties of various pharmacologic groups of drugs].
Topics: Animals; Antiviral Agents; Cardiovascular Agents; Drug Evaluation, Preclinical; Herpesviridae Infections; Mice; Papaverine; Strophanthins | 1992 |
Interaction between leukotriene D4 and adenosine or iloprost in the isolated working guinea-pig heart: prevention of the leukotriene D4 effect.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adenosine; Animals; Cardiac Output; Cardiovascular Agents; Chromones; Coronary Circulation; Epoprostenol; Guinea Pigs; Heart; Iloprost; Image Processing, Computer-Assisted; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Papaverine; SRS-A | 1987 |
[Clinical experiences with the spasmolytic spasmoalgolysin].
Topics: Atropine; Cardiovascular Agents; Muscle Relaxants, Central; Papaverine; Parasympatholytics | 1953 |
Ballistocardiographic studies of ethaverine as a coronary vasodilator; preliminary report.
Topics: Ballistocardiography; Cardiovascular Agents; Coronary Disease; Humans; Muscle Relaxants, Central; Papaverine; Vasodilator Agents | 1954 |
A comparative study of the spasmolytic activities of octaverine, perparine and papaverine.
Topics: Cardiovascular Agents; Muscle Relaxants, Central; Papaverine; Parasympatholytics; Quinolines | 1954 |
[New spasmolytics with papaverine-like action].
Topics: Cardiovascular Agents; Muscle Relaxants, Central; Papaverine; Parasympatholytics | 1954 |
A comparative study of the action of octaverine perparine and papaverine on the circulatory and respiratory systems.
Topics: Cardiovascular Agents; Cardiovascular System; Humans; Muscle Relaxants, Central; Papaverine; Parasympatholytics; Quinolines; Respiratory System | 1954 |
Studies on the use of ethaverine in the treatment of angina pectoris.
Topics: Angina Pectoris; Cardiovascular Agents; Humans; Muscle Relaxants, Central; Papaverine | 1954 |
[Combined application of papaverine with tiphen, dibazol, and salsoline].
Topics: Cardiovascular Agents; Humans; Muscle Relaxants, Central; Papaverine; Salsoline Alkaloids | 1956 |
[Diabetes mellitus and pregnancy: labor induction with compositrin].
Topics: Cardiovascular Agents; Diabetes Mellitus; Ergot Alkaloids; Female; Humans; Labor, Induced; Labor, Obstetric; Oxytocics; Papaverine; Pregnancy; Quinine | 1957 |
The spasmolytic actions of some synthetic compounds related to papaverine.
Topics: Cardiovascular Agents; Muscle Relaxants, Central; Papaverine; Parasympatholytics | 1957 |
[Effect of papaverine and dibazol on coronary circulation rate].
Topics: Cardiovascular Agents; Coronary Circulation; Coronary Vessels; Humans; Muscle Relaxants, Central; Papaverine | 1958 |
[Comparative studies of the effect on isolated uterine muscle and the oxytocic action of papaverine and substances of the diaryl-dialkylaminoalkane series].
Topics: Cardiovascular Agents; Female; Humans; Muscle Relaxants, Central; Myometrium; Oxytocics; Papaverine; Uterus | 1958 |
New indications for the intravenous use of papaverine and perparin.
Topics: Cardiovascular Agents; Injections, Intravenous; Muscle Relaxants, Central; Papaverine | 1960 |
[On the pharmacology of a new papaverine-like substance: N,N'-bis(alpha-phenylbutyrylethanol)-piperazine or P.G. 430].
Topics: Cardiovascular Agents; Muscle Relaxants, Central; Papaverine; Piperazine; Piperazines | 1959 |
An investigation of the pharmacological treatment of angina pectoris.
Topics: Angina Pectoris; Cardiovascular Agents; Epinephrine; Ergot Alkaloids; Nitrites; Oxytocics; Papaverine | 1962 |
[Pharmacological observations on dehydroepiandrosterone papaverine-3-monosulfate (DPMS)].
Topics: Cardiovascular Agents; Dehydroepiandrosterone; Muscle Relaxants, Central; Papaverine | 1963 |
[PHARMACOLOGICAL EFFECTS OF SOME PAPAVERINE ANALOGUES].
Topics: Cardiovascular Agents; Inorganic Chemicals; Muscle Relaxants, Central; Papaverine; Pharmacology; Quinolines; Research | 1963 |
[COMPARATIVE CLINICAL MEASUREMENT OF THE EFFECT OF SPASMOLYTIES. (DATA ON THE CLINICAL PHARMACOLOGY OF NO-SPA)].
Topics: Cardiovascular Agents; Muscle Relaxants, Central; Papaverine; Pharmacology; Vasodilator Agents | 1963 |
[THE CERVIX UTERI AND DRUGS FROM THE OBSTETRICAL VIEWPOINT].
Topics: Cardiovascular Agents; Cervix Uteri; Dihydroergotoxine; Ergot Alkaloids; Estriol; Female; Humans; Hyaluronoglucosaminidase; Labor, Obstetric; Obstetrics; Oxytocics; Papaverine; Pharmacology; Phenethylamines; Pregnancy; Relaxin; Scopolamine | 1964 |
[PHARMACOLOGICAL EFFECTS OF SOME PAPAVERIN DERIVATIVES. II].
Topics: Cardiovascular Agents; Cats; Hypnotics and Sedatives; Mice; Muscle Relaxants, Central; Papaverine; Pharmacology; Rats; Research; Toxicology | 1964 |
[COMPARISON OF THE PERIPHERAL VASODILATOR ACTION OF ATROPINE AND SOME SYNTHETIC SPASMOLYTICS].
Topics: Animals; Atropine; Blood Pressure; Blood Pressure Determination; Cardiovascular Agents; Dogs; Muscle Relaxants, Central; Papaverine; Parasympatholytics; Pharmacology; Quaternary Ammonium Compounds; Research; Vasodilator Agents | 1964 |
[Effect of papaverine, euphylline and dibazole on coronary circulation rate, on cardiac oxygen requirement and on cardiac function].
Topics: Aminophylline; Benzimidazoles; Cardiovascular Agents; Coronary Circulation; Heart; Humans; Muscle Relaxants, Central; Oxygen; Papaverine | 1959 |
Changes in coronary flow reserve following stent implantation in the swine descending thoracic aorta.
Topics: Animals; Aorta, Thoracic; Aortography; Cardiovascular Agents; Compliance; Coronary Circulation; Female; Male; Models, Animal; Papaverine; Regional Blood Flow; Research Design; Stents; Swine; Thermodilution; Time Factors; Vascular Surgical Procedures | 2007 |
Prevention of arterial graft spasm by botulinum toxin: an in-vitro experiment.
Topics: Animals; Aorta, Abdominal; Aortic Diseases; Botulinum Toxins; Cardiovascular Agents; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Myography; Norepinephrine; Papaverine; Potassium Chloride; Rats; Rats, Wistar; Spasm; Time Factors; Vasoconstriction; Vasoconstrictor Agents | 2009 |
PEGylated exendin-4, a modified GLP-1 analog exhibits more potent cardioprotection than its unmodified parent molecule on a dose to dose basis in a murine model of myocardial infarction.
Topics: Aminophylline; Animals; Atropine; Blotting, Western; Cardiovascular Agents; Disease Models, Animal; Drug Combinations; Exenatide; Glucagon-Like Peptide 1; Heart; Heart Function Tests; Histocytochemistry; Male; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Nitroglycerin; Papaverine; Peptides; Phenobarbital; Survival Analysis; Treatment Outcome; Venoms | 2015 |